Global Luciferase Substrate Market Research Report 2024

Publication ID:

PB507248296

Publication Date:

July 3, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

Luciferase substrates are required to generate detectable signals in reporter assays involving luciferase. Such applications include the luciferase assays for gene expression and other cell-based assays. D-Luciferin (particularly firefly luciferin) is perhaps the most common luciferase substrate, but coelenterazine is another chemiluminescent compound catalyzed by luciferase. Coelenterazine may be used to monitor cellular calcium, detect superoxide anions, and other applications involving bioluminescence.
The global Luciferase Substrate market was valued at US$ 835 million in 2023 and is anticipated to reach US$ 1590.5 million by 2030, witnessing a CAGR of 9.2% during the forecast period 2024-2030.
Since the 1980s, with the rapid development of science and technology, especially important breakthroughs in modern biotechnology, monoclonal antibody technology, microelectronic processors, and photochemistry, the global in vitro diagnostic industry has undergone four revolutions: biochemical, enzymatic, immunoassay, and molecular diagnosis. It has passed through its initial and early stages of growth and has formed a mature industry worth hundreds of billions of dollars. From the perspective of market size, the global in vitro diagnostic market has grown steadily in recent years. According to Kalorama information, the overall global IVD market capacity increased from $83.3 billion in 2020 to $117 billion in 2021. Among them, the market size of molecular diagnosis reached US $37.04 billion, accounting for 32%, and the market size of POCT reached US $31.59 billion, accounting for 27%. This is mainly due to the surge in demand brought by COVID-19 testing. From the perspective of regional market pattern, the global IVD demand market is mainly distributed in North America, Europe, Japan and other developed economies, accounting for more than 70% of the market share. The demand is relatively stable, and the United States is the global IVD innovation center and the largest demand market.
This report aims to provide a comprehensive presentation of the global market for Luciferase Substrate, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Luciferase Substrate.
Report Scope
The Luciferase Substrate market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Luciferase Substrate market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Luciferase Substrate manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher Scientific
Abcam
G Biosciences
Tocris Bioscience
R and D Systems
Promega
BioThema
Biotium
RayBiotech
Biorbyt
AAT Bioquest
Segment by Type
D-Luciferin
Coelenterazine
Segment by Application
Life Sciences Laboratories
Clinical Laboratories
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Luciferase Substrate manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Luciferase Substrate in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Luciferase Substrate Market Overview
1.1 Product Overview and Scope of Luciferase Substrate
1.2 Luciferase Substrate Segment by Type
1.2.1 Global Luciferase Substrate Market Value Comparison by Type (2024-2030)
1.2.2 D-Luciferin
1.2.3 Coelenterazine
1.3 Luciferase Substrate Segment by Application
1.3.1 Global Luciferase Substrate Market Value by Application: (2024-2030)
1.3.2 Life Sciences Laboratories
1.3.3 Clinical Laboratories
1.3.4 Others
1.4 Global Luciferase Substrate Market Size Estimates and Forecasts
1.4.1 Global Luciferase Substrate Revenue 2019-2030
1.4.2 Global Luciferase Substrate Sales 2019-2030
1.4.3 Global Luciferase Substrate Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Luciferase Substrate Market Competition by Manufacturers
2.1 Global Luciferase Substrate Sales Market Share by Manufacturers (2019-2024)
2.2 Global Luciferase Substrate Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Luciferase Substrate Average Price by Manufacturers (2019-2024)
2.4 Global Luciferase Substrate Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Luciferase Substrate, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Luciferase Substrate, Product Type & Application
2.7 Luciferase Substrate Market Competitive Situation and Trends
2.7.1 Luciferase Substrate Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Luciferase Substrate Players Market Share by Revenue
2.7.3 Global Luciferase Substrate Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Luciferase Substrate Retrospective Market Scenario by Region
3.1 Global Luciferase Substrate Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Luciferase Substrate Global Luciferase Substrate Sales by Region: 2019-2030
3.2.1 Global Luciferase Substrate Sales by Region: 2019-2024
3.2.2 Global Luciferase Substrate Sales by Region: 2025-2030
3.3 Global Luciferase Substrate Global Luciferase Substrate Revenue by Region: 2019-2030
3.3.1 Global Luciferase Substrate Revenue by Region: 2019-2024
3.3.2 Global Luciferase Substrate Revenue by Region: 2025-2030
3.4 North America Luciferase Substrate Market Facts & Figures by Country
3.4.1 North America Luciferase Substrate Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Luciferase Substrate Sales by Country (2019-2030)
3.4.3 North America Luciferase Substrate Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Luciferase Substrate Market Facts & Figures by Country
3.5.1 Europe Luciferase Substrate Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Luciferase Substrate Sales by Country (2019-2030)
3.5.3 Europe Luciferase Substrate Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Luciferase Substrate Market Facts & Figures by Country
3.6.1 Asia Pacific Luciferase Substrate Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Luciferase Substrate Sales by Country (2019-2030)
3.6.3 Asia Pacific Luciferase Substrate Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Luciferase Substrate Market Facts & Figures by Country
3.7.1 Latin America Luciferase Substrate Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Luciferase Substrate Sales by Country (2019-2030)
3.7.3 Latin America Luciferase Substrate Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Luciferase Substrate Market Facts & Figures by Country
3.8.1 Middle East and Africa Luciferase Substrate Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Luciferase Substrate Sales by Country (2019-2030)
3.8.3 Middle East and Africa Luciferase Substrate Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Luciferase Substrate Sales by Type (2019-2030)
4.1.1 Global Luciferase Substrate Sales by Type (2019-2024)
4.1.2 Global Luciferase Substrate Sales by Type (2025-2030)
4.1.3 Global Luciferase Substrate Sales Market Share by Type (2019-2030)
4.2 Global Luciferase Substrate Revenue by Type (2019-2030)
4.2.1 Global Luciferase Substrate Revenue by Type (2019-2024)
4.2.2 Global Luciferase Substrate Revenue by Type (2025-2030)
4.2.3 Global Luciferase Substrate Revenue Market Share by Type (2019-2030)
4.3 Global Luciferase Substrate Price by Type (2019-2030)
5 Segment by Application
5.1 Global Luciferase Substrate Sales by Application (2019-2030)
5.1.1 Global Luciferase Substrate Sales by Application (2019-2024)
5.1.2 Global Luciferase Substrate Sales by Application (2025-2030)
5.1.3 Global Luciferase Substrate Sales Market Share by Application (2019-2030)
5.2 Global Luciferase Substrate Revenue by Application (2019-2030)
5.2.1 Global Luciferase Substrate Revenue by Application (2019-2024)
5.2.2 Global Luciferase Substrate Revenue by Application (2025-2030)
5.2.3 Global Luciferase Substrate Revenue Market Share by Application (2019-2030)
5.3 Global Luciferase Substrate Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Thermo Fisher Scientific
6.1.1 Thermo Fisher Scientific Corporation Information
6.1.2 Thermo Fisher Scientific Description and Business Overview
6.1.3 Thermo Fisher Scientific Luciferase Substrate Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Thermo Fisher Scientific Luciferase Substrate Product Portfolio
6.1.5 Thermo Fisher Scientific Recent Developments/Updates
6.2 Abcam
6.2.1 Abcam Corporation Information
6.2.2 Abcam Description and Business Overview
6.2.3 Abcam Luciferase Substrate Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Abcam Luciferase Substrate Product Portfolio
6.2.5 Abcam Recent Developments/Updates
6.3 G Biosciences
6.3.1 G Biosciences Corporation Information
6.3.2 G Biosciences Description and Business Overview
6.3.3 G Biosciences Luciferase Substrate Sales, Revenue and Gross Margin (2019-2024)
6.3.4 G Biosciences Luciferase Substrate Product Portfolio
6.3.5 G Biosciences Recent Developments/Updates
6.4 Tocris Bioscience
6.4.1 Tocris Bioscience Corporation Information
6.4.2 Tocris Bioscience Description and Business Overview
6.4.3 Tocris Bioscience Luciferase Substrate Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Tocris Bioscience Luciferase Substrate Product Portfolio
6.4.5 Tocris Bioscience Recent Developments/Updates
6.5 R and D Systems
6.5.1 R and D Systems Corporation Information
6.5.2 R and D Systems Description and Business Overview
6.5.3 R and D Systems Luciferase Substrate Sales, Revenue and Gross Margin (2019-2024)
6.5.4 R and D Systems Luciferase Substrate Product Portfolio
6.5.5 R and D Systems Recent Developments/Updates
6.6 Promega
6.6.1 Promega Corporation Information
6.6.2 Promega Description and Business Overview
6.6.3 Promega Luciferase Substrate Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Promega Luciferase Substrate Product Portfolio
6.6.5 Promega Recent Developments/Updates
6.7 BioThema
6.6.1 BioThema Corporation Information
6.6.2 BioThema Description and Business Overview
6.6.3 BioThema Luciferase Substrate Sales, Revenue and Gross Margin (2019-2024)
6.4.4 BioThema Luciferase Substrate Product Portfolio
6.7.5 BioThema Recent Developments/Updates
6.8 Biotium
6.8.1 Biotium Corporation Information
6.8.2 Biotium Description and Business Overview
6.8.3 Biotium Luciferase Substrate Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Biotium Luciferase Substrate Product Portfolio
6.8.5 Biotium Recent Developments/Updates
6.9 RayBiotech
6.9.1 RayBiotech Corporation Information
6.9.2 RayBiotech Description and Business Overview
6.9.3 RayBiotech Luciferase Substrate Sales, Revenue and Gross Margin (2019-2024)
6.9.4 RayBiotech Luciferase Substrate Product Portfolio
6.9.5 RayBiotech Recent Developments/Updates
6.10 Biorbyt
6.10.1 Biorbyt Corporation Information
6.10.2 Biorbyt Description and Business Overview
6.10.3 Biorbyt Luciferase Substrate Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Biorbyt Luciferase Substrate Product Portfolio
6.10.5 Biorbyt Recent Developments/Updates
6.11 AAT Bioquest
6.11.1 AAT Bioquest Corporation Information
6.11.2 AAT Bioquest Luciferase Substrate Description and Business Overview
6.11.3 AAT Bioquest Luciferase Substrate Sales, Revenue and Gross Margin (2019-2024)
6.11.4 AAT Bioquest Luciferase Substrate Product Portfolio
6.11.5 AAT Bioquest Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Luciferase Substrate Industry Chain Analysis
7.2 Luciferase Substrate Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Luciferase Substrate Production Mode & Process
7.4 Luciferase Substrate Sales and Marketing
7.4.1 Luciferase Substrate Sales Channels
7.4.2 Luciferase Substrate Distributors
7.5 Luciferase Substrate Customers
8 Luciferase Substrate Market Dynamics
8.1 Luciferase Substrate Industry Trends
8.2 Luciferase Substrate Market Drivers
8.3 Luciferase Substrate Market Challenges
8.4 Luciferase Substrate Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Thermo Fisher Scientific
Abcam
G Biosciences
Tocris Bioscience
R and D Systems
Promega
BioThema
Biotium
RayBiotech
Biorbyt
AAT Bioquest

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂